Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Zenaty

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Annales D'Endocrinologie|November 28, 2017
Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortalityOlivier Chabre, Bernard Goichot, Delphine Zenaty, et al.
Annales D'Endocrinologie|November 30, 2017
Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient educationLaurence Guignat, Emmanuelle Proust-Lemoine, Yves Reznik, et al.
Clinical Endocrinology|April 18, 2003
Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiencyDelphine Zenaty, Catherine Garel, Costanzo Limoni, et al.
Annales D'Endocrinologie|November 28, 2017
Group 5: Acute adrenal insufficiency in adults and pediatric patientsChristine Cortet, Pascal Barat, Delphine Zenaty, et al.
La Revue Du Praticien|August 22, 2008
[Precocious pubertal]Jean-Claude Carel, Delphine Zenaty, Anne Paulsen, et al.
European Journal of Endocrinology|January 9, 2016
X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndromeElodie Fiot, Delphine Zenaty, Priscilla Boizeau, et al.
Hormone Research in Paediatrics|September 8, 2016
A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin AcetateDelphine Zenaty, Joelle Blumberg, Nilani Liyanage, et al.
European Journal of Endocrinology|August 4, 2016
X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndromeElodie Fiot, Delphine Zenaty, Priscilla Boizeau, et al.
International Journal of Paediatric Dentistry|June 12, 2010
Dental agenesis in Kallmann syndrome individuals with FGFR1 mutationsIsabelle Bailleul-Forestier, Catherine Gros, Delphine Zenaty, et al.
Molecular and Cellular Endocrinology|June 8, 2006
Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1)Delphine Zenaty, Patricia Bretones, Cécile Lambe, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annales D'Endocrinologie|November 28, 2017
Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortalityOlivier Chabre, Bernard Goichot, Delphine Zenaty, et al.
Annales D'Endocrinologie|November 30, 2017
Group 6. Modalities and frequency of monitoring of patients with adrenal insufficiency. Patient educationLaurence Guignat, Emmanuelle Proust-Lemoine, Yves Reznik, et al.
Clinical Endocrinology|April 18, 2003
Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiencyDelphine Zenaty, Catherine Garel, Costanzo Limoni, et al.
Annales D'Endocrinologie|November 28, 2017
Group 5: Acute adrenal insufficiency in adults and pediatric patientsChristine Cortet, Pascal Barat, Delphine Zenaty, et al.
La Revue Du Praticien|August 22, 2008
[Precocious pubertal]Jean-Claude Carel, Delphine Zenaty, Anne Paulsen, et al.
European Journal of Endocrinology|January 9, 2016
X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndromeElodie Fiot, Delphine Zenaty, Priscilla Boizeau, et al.
Hormone Research in Paediatrics|September 8, 2016
A 6-Month Trial of the Efficacy and Safety of Triptorelin Pamoate (11.25 mg) Every 3 Months in Children with Precocious Puberty: A Retrospective Comparison with Triptorelin AcetateDelphine Zenaty, Joelle Blumberg, Nilani Liyanage, et al.
European Journal of Endocrinology|August 4, 2016
X-chromosome gene dosage as a determinant of impaired pre and postnatal growth and adult height in Turner syndromeElodie Fiot, Delphine Zenaty, Priscilla Boizeau, et al.
International Journal of Paediatric Dentistry|June 12, 2010
Dental agenesis in Kallmann syndrome individuals with FGFR1 mutationsIsabelle Bailleul-Forestier, Catherine Gros, Delphine Zenaty, et al.
Molecular and Cellular Endocrinology|June 8, 2006
Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1)Delphine Zenaty, Patricia Bretones, Cécile Lambe, et al.
Pageof 3